PP_1170x120_10-25-21

Mark McKenna

US WorldMeds and Salix announce U.S. roll out of Lucemyra

US WorldMeds and Salix announce U.S. roll out of Lucemyra

LOUISVILLE, K.Y. and BIDGEWATER, N.J. – US WorldMeds, LLC, and Salix Pharmaceuticals, a wholly owned subsidiary of Bausch Health Companies Inc., today announced the U.S. launch and availability of Lucemyra (lofexidine) 0.18 mg tablets, the first and only non-opioid medication indicated for mitigation of opioid withdrawal symptoms to facilitate abrupt opioid discontinuation in adults. The Centers